MDL 29951

CAS No. 130798-51-5

MDL 29951( MDL 29951 | MDL-29951 | MDL29951 | MDL 29,951 )

Catalog No. M11231 CAS No. 130798-51-5

MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 87 In Stock
5MG 159 In Stock
10MG 285 In Stock
25MG 516 In Stock
50MG 741 In Stock
100MG 1017 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MDL 29951
  • Note
    Research use only, not for human use.
  • Brief Description
    MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
  • Description
    MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    MDL 29951 | MDL-29951 | MDL29951 | MDL 29,951
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    NMDAR
  • Recptor
    NMDA receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    130798-51-5
  • Formula Weight
    302.11
  • Molecular Formula
    C12H9Cl2NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(O)CCC1=C(C(O)=O)NC2=C1C(Cl)=CC(Cl)=C2
  • Chemical Name
    2-Carboxy-4,6-dichloro-1H-indole-3-propanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Baron BM, et al. J Pharmacol Exp Ther. 1992 Sep;262(3):947-56.
molnova catalog
related products
  • Riluzole

    Riluzole is a sodium channel protein inhibitor and potent neuroprotective agent.

  • TCN213

    TCN213 is an antagonist of NMDA receptor that has a selective for NR1/NR2A over NR1/NR2BTCN 213 antagonism of GluN1/GluN2A NMDA receptors was dependent on glycine but independent of glutamate concentrations in external recording solutions.

  • NMDA-IN-1

    NMDA-IN-1 is a potent and NR2B-selective antagonist of NMDA(NMDA Ki of 0.85 nM; NR2B Ca2+ influx IC50 is 9.7 nM).